Free Trial

Savaria (TSE:SIS) Price Target Raised to C$35.00

Savaria logo with Industrials background
Image from MarketBeat Media, LLC.

Key Points

  • TD Securities raised Savaria's price target to C$35.00 (from C$31.00) and maintained a "buy" rating, implying roughly a 21.7% upside from the prior close.
  • Multiple brokers lifted their targets recently and the consensus from analysts is a Buy with an average target of C$32.19.
  • Shares traded at C$28.76 (market cap C$2.07B, PE 29.96), and an insider bought 2,420 shares — insiders now own 17.45% of the company.
  • Five stocks we like better than Savaria.

Savaria (TSE:SIS - Get Free Report) had its target price hoisted by TD from C$31.00 to C$35.00 in a report released on Wednesday,BayStreet.CA reports. The firm presently has a "buy" rating on the stock. TD's price objective would suggest a potential upside of 21.70% from the company's previous close.

A number of other brokerages also recently commented on SIS. TD Securities upped their price objective on shares of Savaria from C$27.00 to C$31.00 and gave the stock a "buy" rating in a research report on Thursday, March 5th. ATB Cormark Capital Markets increased their target price on Savaria from C$30.00 to C$32.00 and gave the stock an "outperform" rating in a research note on Friday, March 6th. National Bank Financial increased their target price on Savaria from C$30.00 to C$30.50 and gave the stock an "outperform" rating in a research note on Friday, March 6th. Scotiabank increased their target price on Savaria from C$29.00 to C$30.00 and gave the stock an "outperform" rating in a research note on Friday, March 6th. Finally, Raymond James Financial increased their target price on Savaria from C$27.00 to C$32.00 and gave the stock an "outperform" rating in a research note on Friday, March 6th. Eight research analysts have rated the stock with a Buy rating, According to data from MarketBeat, Savaria currently has a consensus rating of "Buy" and an average target price of C$32.19.

Check Out Our Latest Stock Analysis on Savaria

Savaria Stock Performance

SIS traded down C$0.19 on Wednesday, hitting C$28.76. 295,917 shares of the company traded hands, compared to its average volume of 181,278. The company has a 50 day moving average of C$26.01 and a 200-day moving average of C$23.67. The company has a quick ratio of 0.91, a current ratio of 1.61 and a debt-to-equity ratio of 32.13. The stock has a market capitalization of C$2.07 billion, a PE ratio of 29.96, a PEG ratio of 42.72 and a beta of 0.86. Savaria has a 12-month low of C$16.11 and a 12-month high of C$30.41.

Savaria (TSE:SIS - Get Free Report) last announced its quarterly earnings data on Wednesday, March 4th. The company reported C$0.37 EPS for the quarter. The company had revenue of C$241.78 million during the quarter. Savaria had a net margin of 7.53% and a return on equity of 11.10%. Sell-side analysts anticipate that Savaria will post 1.2048518 earnings per share for the current year.

Insider Activity at Savaria

In other news, insider Jean-Philippe De Montigny purchased 2,420 shares of the stock in a transaction dated Friday, March 20th. The stock was acquired at an average cost of C$25.50 per share, for a total transaction of C$61,710.00. Following the completion of the acquisition, the insider directly owned 92,260 shares in the company, valued at C$2,352,630. This represents a 2.69% increase in their position. 17.45% of the stock is currently owned by company insiders.

Savaria Company Profile

(Get Free Report)

Savaria Corporation ( savaria.com ) is a global leader in the accessibility industry. It provides accessibility solutions for the physically challenged to increase their comfort, their mobility and their independence. Its product line is one of the most comprehensive on the market. Savaria designs, manufactures, distributes and installs accessibility equipment, such as stairlifts for straight and curved stairs, vertical and inclined wheelchair lifts and elevators for home and commercial use. It also manufactures and markets a comprehensive selection of pressure management products for the medical market, medical beds for the long-term care market, as well as an extensive line of medical equipment and solutions for the safe handling of patients, including ceiling lifts and slings.

See Also

Analyst Recommendations for Savaria (TSE:SIS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Savaria Right Now?

Before you consider Savaria, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Savaria wasn't on the list.

While Savaria currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines